Merck’s healthcare division in Canada and the US, EMD Serono, has signed an agreement with the Trump administration to expand ...

EMD Serono, the healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, and President Donald J.

Trump and EMD Serono strike a deal to cut fertility drug costs, expand U.S. manufacturing, and launch the TrumpRx Fertility ...

EMD Serono will sell fertility drugs on the Trump direct-to-consumer marketplace. Trump also preview plans to encourage ...

In today’s Pharmaceutical Executive Daily, we explore how antibody-drug conjugate collaborations are moving beyond oncology ...

The Trump administration announced that Boston-based drugmaker EMD Serono will lower the price of one of its leading ...

President Donald Trump made an announcement Thursday from the Oval Office that EMD Serono will reduce the cost of fertility ...

EMD Serono offers IVF drugs at significant savings via TrumpRx, saving women thousands of dollars per treatment cycle. Read ...

EMD Serono's agreement with the US government aims to expand IVF therapy access for 10 million women, offering significant ...

EMD Serono will offer its fertility treatments on TrumpRx at a steep discount, and Roche’s direct-to-consumer offering will ...

EMD Serono also entered an agreement with the U.S. Secretary of Commerce to exclude its pharmaceutical products and ...

Fertility drugmaker EMD Serono, the U.S. arm of Merck KGaA, will offer its in vitro fertilization (IVF) treatments at a sharp discount on the government's DTC platform TrumpRx.